Canada

C$CAD

$USD

Call

Connect with us for legal assistance

(+1) 587 680-0257

Need help? Drop us an email

Email Us

Need a quick help? Leave us a message

Text Us

Trademark Search in Canada

ABDERA THERAPEUTICS

View On IC.GC.CA

APPROVED

on 5 May 2025

Last Applicant/ Owned by

Abdera Therapeutics Inc.

910 Gateway BoulevardSouth San Francisco, CA 94080

Serial Number

2199693 filed on 21^st Jul 2022

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

M5X1G5

ABDERA THERAPEUTICS

Trademark usage description

pharmaceutical preparations for the treatment of cancer; chemical preparations for the treatment, prevention, or diagnosis of cancer; pharmaceutical d Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of cancer; Chemical preparations for the treatment, prevention, or diagnosis of cancer; pharmaceutical drugs used for the treatment, prevention, or diagnosis of cancer; radiopharmaceutical products used for the treatment, prevention, and diagnosis of cancer; pharmaceutical products for use in relation to radiotherapy, namely, products to target and treat tumors and cancer; pharmaceutical preparations, namely, pharmaceuticals using alpha radiation therapies for the treatment of cancer; diagnostic radiopharmaceutical imaging agents for use in diagnosing cancer

Classification kind code

Class [010]
Syringes for injections; syringes for medical use; medical kits comprised of single and multi-dose vials and syringes to administer pharmaceutical products used for the treatment, prevention, and diagnosis of cancer;

Classification kind code

Class [042]
Pharmaceutical research and development; pharmaceutical drug development services, namely, drug development for the treatment of cancer; research and development of pharmaceutical products using radiotherapy to target and treat tumors andcancer;

Classification kind code

Mark Details

Serial Number

2199693

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 5^th May 2025	Approved
Submitted for opposition 27 on 5^th May 2025	Approval Notice Sent
Submitted for opposition 22 on 24^th Mar 2025	Search Recorded
Submitted for opposition 20 on 24^th Mar 2025	Examiner's First Report
Submitted for opposition 135 on 21^st Feb 2025	Amendment to Application
Submitted for opposition 80 on 15^th Jun 2023	Change of Title Registered
Submitted for opposition 287 on 28^th Jul 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 21^st Jul 2022	Filed
Submitted for opposition 1 on 21^st Jul 2022	Created
Submitted for opposition 31 on 21^st Jul 2022	Formalized

ABDERA THERAPEUTICS

Classification Information

Classification kind code

Class [010]Syringes for injections; syringes for medical use; medical kits comprised of single and multi-dose vials and syringes to administer pharmaceutical products used for the treatment, prevention, and diagnosis of cancer;

Classification kind code

Class [042]Pharmaceutical research and development; pharmaceutical drug development services, namely, drug development for the treatment of cancer; research and development of pharmaceutical products using radiotherapy to target and treat tumors andcancer;

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [010]
Syringes for injections; syringes for medical use; medical kits comprised of single and multi-dose vials and syringes to administer pharmaceutical products used for the treatment, prevention, and diagnosis of cancer;

Class [042]
Pharmaceutical research and development; pharmaceutical drug development services, namely, drug development for the treatment of cancer; research and development of pharmaceutical products using radiotherapy to target and treat tumors andcancer;